Orthofix Medical Inc. Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)
Orthofix Medical Inc. (OFIX) reported Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-25.
Financial Statements › Notes
us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease · last filed 2025-02-25
- Orthofix Medical Inc. accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2023-12-31 was $0.00.
- Orthofix Medical Inc. accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2023-09-30 was $0.00.
- Orthofix Medical Inc. accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2023-06-30 was $0.00.
- Orthofix Medical Inc. accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2023-03-31 was $137.00K.
- Orthofix Medical Inc. accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Orthofix Medical Inc. accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2023 was $137.00K.
- Orthofix Medical Inc. accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2013 was $242.00K.
| Period end | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 3 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 6 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 9 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-25 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $0.00 derived: sum of 2 quarters · filed 2025-02-25 | $0.00 derived: sum of 3 quarters · filed 2025-02-25 | $137.00K 10-K · filed 2025-02-25 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $137.00K 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $137.00K 10-Q · filed 2024-08-06 | ||
| 2023-03-31 | $137.00K 10-Q · filed 2024-05-07 | |||
| 2013-12-31 | $242.00K 10-K/A · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |